CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Effects of ezetimibe on LDL receptor- and HMG-CoA reductase-gene expression, on LDL receptor protein expression and on HMG-CoA reductase activity in mononuclear blood cells of healthy men – A randomized trial
DOI 10.1055/s-2006-943778
Bibliografische Angaben
Nachweis in CareLit
Autor:innenI Berthold, Y Ko, S Stier, E Giannakidou, H Gylling, J Plat, HK Berthold, W Krone
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe06/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose of the study: Achieving target LDL-cholesterol (LDL-C) levels is of utmost importance, especially in patients with diabetes mellitus. The combination of simvastatin and the cholesterol absorption inhibitor ezetimibe is widely used to attain this goal. Purpose of the present study was to examine the effects of these agents and their combination on LDL-receptor- (LDLR) and HMG-CoA reductase-gene expression, on…
Zitieren
Zitierempfehlung
I Berthold, Y Ko, S Stier, E Giannakidou, H Gylling, J Plat, HK Berthold, W Krone (2006) Effects of ezetimibe on LDL receptor- and HMG-CoA reductase-gene expression, on LDL receptor protein expression and on HMG-CoA reductase activity in mononuclear blood cells of healthy men – A randomized trial. Diabetologie und Stoffwechsel (06). https://doi.org/10.1055/s-2006-943778
Mit CareLit weiterarbeiten